SARA ROBERSON: Open Payments
NPI 1285862540 · WALDRON, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$736 in 46 payments from 10 companies in 2025. Trend: 2023 $218 · 2024 $628 · 2025 $736
Food & beverage: $736
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $234 |
| AstraZeneca Pharmaceuticals LP | 6 | $168 |
| ABBVIE INC. | 11 | $166 |
| Exact Sciences Corporation | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| Lundbeck LLC | 1 | $23 |
| Alkermes, Inc. | 1 | $22 |
| Amgen Inc. | 1 | $21 |
| Electromed, Inc. | 3 | $18 |
| The Binding Site Inc. | 1 | $18 |
Products named: CAPLYTA, VRAYLAR, AIRSUPRA, BREZTRI, Cologuard Collection Kit, Kerendia, REXULTI, ARISTADA.
Industry payments across AR — which companies pay providers there.
